Nuravi is building the operating system for PCOS — diagnosis, daily tracking, and clinically formulated protocols. We are opening a small number of partnerships with investors, clinics, researchers, and ambassadors ready to move at our pace.
1 in 10 women has PCOS. Most are diagnosed late, told to lose weight, and handed nothing else. The category has no consumer-facing brand of record. Nuravi is building it from the diagnosis layer up — software, supplements, and clinical care, designed to compound.
We are selectively raising from operators and funds with conviction in women's health, consumer health, and vertically integrated brands.
We work with endocrinologists, OB-GYNs, dietitians, and academic groups to ground every protocol in evidence and to run real-world studies on outcomes.
Clinicians, dietitians, coaches, and creators who already serve women with PCOS. Refer your clients, get early access, and shape the protocols you would actually recommend.
We are a category-defining women's health company building software, supplements, and clinical workflows in one stack. Below is the short version. The full data room is shared after a first conversation.
Vertically integrated PCOS platform — diagnosis quiz, Balance App, and three clinical supplement protocols (Glow, Balance, Cycle).
Balance App live in the App Store with 62% 30-day retention and a 12,000+ waitlist for supplements pre-launch.
Founder team with lived PCOS experience and prior consumer health, ML, and supply chain operating roles.
Capital efficient model — recurring supplement subscriptions, app subscription, and a clinical revenue layer in 2027.
Send a short note and we will route it to the right person on the team. Investors and partners hear back within five business days.